Literature DB >> 2980178

Maggot therapy: a review of the therapeutic applications of fly larvae in human medicine, especially for treating osteomyelitis.

R A Sherman1, E A Pechter.   

Abstract

In traditional medical practice, the larvae of some Diptera: Calliphoridae, notably Lucilia illustris (Meigen), L.sericata (Meigen) and Phormia regina (Meigen), have been employed for maggot therapy, i.e. to help clean lesions antiseptically, especially for treatment of chronic osteomyelitis. This mode of treatment remains appropriate for cases where antibiotics are ineffective and surgery impracticable.

Entities:  

Mesh:

Year:  1988        PMID: 2980178     DOI: 10.1111/j.1365-2915.1988.tb00188.x

Source DB:  PubMed          Journal:  Med Vet Entomol        ISSN: 0269-283X            Impact factor:   2.739


  21 in total

Review 1.  The efficacy of maggot debridement therapy--a review of comparative clinical trials.

Authors:  Kian Zarchi; Gregor B E Jemec
Journal:  Int Wound J       Date:  2012-01-17       Impact factor: 3.315

Review 2.  Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential.

Authors:  Iain S Whitaker; Christopher Twine; Michael J Whitaker; Mathew Welck; Charles S Brown; Ahmed Shandall
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

3.  First case reports of Ignatzschineria (Schineria) indica associated with myiasis.

Authors:  Heather S Barker; James W Snyder; Adam B Hicks; Stephen P Yanoviak; Paul Southern; Bijaya K Dhakal; Giri R Ghimire; Marc R Couturier
Journal:  J Clin Microbiol       Date:  2014-10-08       Impact factor: 5.948

4.  Viability of Lucilia sericata maggots after exposure to wound antiseptics.

Authors:  Georg Daeschlein; Matthias Napp; Ojan Assadian; Sebastian von Podewils; Kevin Reese; Peter Hinz; Johannes Matiasek; Romy Spitzmueller; Paul Humphreys; Michael Jünger; Axel Kramer
Journal:  Int Wound J       Date:  2016-07-11       Impact factor: 3.315

5.  Maggot debridement therapy for peripheral arterial disease.

Authors:  Kimihiro Igari; Takahiro Toyofuku; Hidetoshi Uchiyama; Shinya Koizumi; Koji Yonekura; Toshifumi Kudo; Masatoshi Jibiki; Norihide Sugano; Yoshinori Inoue
Journal:  Ann Vasc Dis       Date:  2013-05-30

6.  Evaluation of larval density Cochliomyia macellaria F. (Diptera: Calliphoridae) for therapeutic use in the recovery of tegumentar injuries.

Authors:  Mariana Prado Nassu; Patricia Jacqueline Thyssen
Journal:  Parasitol Res       Date:  2015-05-30       Impact factor: 2.289

7.  Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.

Authors:  Aaron G Paul; Nazni W Ahmad; H L Lee; Ashraff M Ariff; Masri Saranum; Amara S Naicker; Zulkiflee Osman
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

8.  A novel approach to the antimicrobial activity of maggot debridement therapy.

Authors:  Anders S Andersen; Dorthe Sandvang; Kirk M Schnorr; Thomas Kruse; Søren Neve; Bo Joergensen; Tonny Karlsmark; Karen A Krogfelt
Journal:  J Antimicrob Chemother       Date:  2010-06-11       Impact factor: 5.790

9.  The influence of maggot excretions on PAO1 biofilm formation on different biomaterials.

Authors:  Gwendolyn Cazander; Kiril E B van Veen; Lee H Bouwman; Alexandra T Bernards; Gerrolt N Jukema
Journal:  Clin Orthop Relat Res       Date:  2008-10-16       Impact factor: 4.176

10.  Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

Authors:  Jo C Dumville; Gill Worthy; J Martin Bland; Nicky Cullum; Christopher Dowson; Cynthia Iglesias; Joanne L Mitchell; E Andrea Nelson; Marta O Soares; David J Torgerson
Journal:  BMJ       Date:  2009-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.